Search CNMD
CONMED Corp
NYSE · CIK 816956
Last close46.32
Daily change+0.39 (0.85%)
10 Years gain+34.85%
Dividends TTM0 (-100.00%)
Dividend yield0.00%
Fundamental Analysis
CNMD · STANDARD
SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Fiscal year end 1231
Fundamental
42.4Momentum
17.7Acceleration
10.9Confidence
91.0Annual Revenue17
Quarterly Revenue72
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth7.5 / 25
Quality11.3 / 25
Capital Efficiency3.0 / 20
Balance Sheet9.0 / 15
Shareholder Economics9.5 / 10
Forward Indicators0.0 / 5
Signals
Share count reductionDiluted share count declined 3.1981%.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 6.4604 percentage points.
ROIC declining · MEDIUMROIC declined by 9.8692 percentage points.
Key Metrics
Revenue Growth TTM6.27%OK
Revenue CAGR 3Y9.56%OK
Gross Margin54.25%OK
Operating Margin7.61%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC7.87%OK
Incremental Operating Margin 3Y2.04%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-3.2%OK
SBC / Revenue2.13%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.37B | $750.48M | $102.62M | $170.69M | $150.88M | 54.59% | 7.46% | 10.98% | 7.03% | 31.15M |
| 2025 FY Dec 31, 2024 | $1.31B | $733.03M | $200.33M | $166.97M | $153.88M | 56.08% | 15.33% | 11.77% | 18.62% | 31.15M |
| 2025 FY Dec 31, 2023 | $1.24B | $676.25M | $120.60M | $125.35M | $106.32M | 54.33% | 9.69% | 8.54% | 12.6% | 31.55M |
| 2024 FY Dec 31, 2022 | $1.05B | $571.25M | $70.05M | $33.37M | $11.58M | 54.64% | 6.7% | 1.11% | 7.47% | 30.04M |
| 2023 FY Dec 31, 2021 | $1.01B | $568.04M | $109.72M | $111.77M | $96.90M | 56.21% | 10.86% | 9.59% | 12.98% | 32.22M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.35B | sum latest 4 fiscal quarters Revenue | OK | 0000816956-25-000011, 0000816956-26-000102 |
| Revenue Growth TTM | 6.27% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000816956-25-000011, 0000816956-26-000102 |
| Revenue CAGR 3Y | 9.56% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000816956-26-000009 |
| Revenue CAGR 5Y | 9.77% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000816956-26-000009 |
| Gross Profit CAGR 3Y | 9.52% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000816956-26-000009 |
| Operating Income Growth | -42.51% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000816956-25-000011, 0000816956-26-000102 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.25% | Gross Profit / Revenue | OK | 0000816956-25-000011, 0000816956-26-000102 |
| Operating Margin | 7.61% | Operating Income / Revenue | OK | 0000816956-25-000011, 0000816956-26-000102 |
| ROIC | 7.87% | NOPAT / Average Invested Capital | OK | 0000816956-25-000011, 0000816956-26-000102 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000816956-26-000102 |
| Interest Coverage | 3.24x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.48x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 2.13% | SBC / Revenue | OK | 0000816956-25-000011, 0000816956-26-000102 |